SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Does the Market Share of Generic Medicines Influence the Price Level?
9 references·1 citing·45 second hop
Does the Market Share of Generic Medicines Influence the Price Level? (2011)Does the Market Share of Generic Medicine…Ongoing pharmaceutical reforms in France (2010)Ongoing pharmaceutical reform…Impact of European Pharmaceutical Price Regulation on Generic Price Competition (2010)Impact of European Pharmaceut…Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation? (2008)Regulation and pricing of pha…International comparison of generic medicine prices (2007)International comparison of g…Sustaining Generic Medicines Markets in Europe (2006)Sustaining Generic Medicines …Dynamic competition in pharmaceuticals (2004)Dynamic competition in pharma…The effect of generic competition on the price of brand-name drugs (2003)The effect of generic competi…The pharmaceutical industry as a medicines provider (2002)The pharmaceutical industry a…A comparative analysis of generics markets in five European countries (2000)A comparative analysis of gen…Generic Medicines: Solutions for a Sustainable Drug Market? (2013)Generic Medicines: Solutions …Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance (2009)Soft regulations in pharmaceutical policy making (2009)Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe? (2010)Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications (2012)Estonia: Health System Review. (2013)Does Regulation Drive Out Competition in Pharmaceutical Markets? (2000)Generic Drug Industry Dynamics (2005)Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2006)Pharmaceutical Prices under Regulation: Tiered Co-payments and Reference Pricing in Germany (2012)Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2014)Biosimilars: How Can Payers Get Long-Term Savings? (2016)Empirical studies of innovation and market structure (1989)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Dynamic count data models of technological innovation (1994)Generic Medicine Pricing Policies in Europe: Current Status and Impact (2010)Determinants of branded prescription medicine prices in OECD countries (2011)Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm (2011)Review of the literature on reference pricing (2000)Encouraging the use of generic medicines: implications for transition economies. (2002)Competition in off-patent drug markets: Issues, regulation and evidence (2008)Physician Agency and Adoption of Generic Pharmaceuticals (2012)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)Cross-national price differences for pharmaceuticals: how large, and why? (2000)Pharmaceutical Pricing Policies in a Global Market (2008)Price control as a strategy for pharmaceutical cost containment—What has been achieved in Norway in the period 1994–2004? (2008)European countries with small populations can obtain low prices for drugs: Lithuania as a case history (2011)Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Generic Entry and the Pricing of Pharmaceuticals (1997)Reforms in the Greek pharmaceutical market during the financial crisis (2012)The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review (2018)What is the impact of intellectual property rules on access to medicines? A systematic review (2022)Cost of innovation in the pharmaceutical industry (1991)Success rates for new drugs entering clinical testing in the United States (1995)Access to Essential Drugs in Poor Countries (1999)GLOBAL TRADE AND PUBLIC HEALTH (2005)Prices & availability of common medicines at six sites in India using a standard methodology. (2007)The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries (2008)Estimating the Effect of Training Programs on Earnings (1978)Evaluating the Effect of Teachers’ Group Performance Incentives on Pupil Achievement (2002)Reference pricing of pharmaceuticals (2006)Effects of Reference Pricing in Pharmaceutical Markets (2010)Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark (2014)What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden (2004)Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals (2006)
this work references cited by second hop

References

  • 2002The pharmaceutical industry as a medicines provider165 cited
  • 2006Sustaining Generic Medicines Markets in Europe161 cited
  • 2008Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?153 cited
  • 2000A comparative analysis of generics markets in five European countries127 cited
  • 2010Impact of European Pharmaceutical Price Regulation on Generic Price Competition114 cited
  • 2010Ongoing pharmaceutical reforms in France108 cited
  • 2003The effect of generic competition on the price of brand-name drugs97 cited
  • 2007International comparison of generic medicine prices86 cited
  • 2004Dynamic competition in pharmaceuticals85 cited

Cited by

  • 2013Generic Medicines: Solutions for a Sustainable Drug Market?67 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work